No Data
No Data
12 Health Care Stocks Moving In Tuesday's After-Market Session
Lixte Biotechnology Files to Sell 467,393 Shares of Common Stock for Holders
LIXTE Launches New Study to Determine If Certain Pre-Cancerous Cells Found in an Aging Population Can Be Eliminated by LB-100
Lixte Biotechnology Provides Update on Progress With LB-100
Express News | Lixte Biotechnology Provides Update on Progress With Proprietary Compound, Lb-100, to Treat Ovarian and Colorectal Cancer
LIXTE Biotechnology Provides Update On Progress With Proprietary Compound, LB-100, to Treat Ovarian and Colorectal Cancer